PRADAXA
|
Boehringer Ingelheim
|
dabigatrán |
Anticoagulante |
110 mg caps.x 10 | $79612.10 | (06/04/24) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $15478.18 |
|
|
|
|
110 mg caps.x 30 | $113638.89 | (06/04/24) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $22093.61 |
|
|
|
|
110 mg caps.x 60 | $215914.35 | (06/04/24) |
|
|
150 mg caps.x 30 | $113638.89 | (06/04/24) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $22093.61 |
|
|
|
|
150 mg caps.x 60 | $215914.35 | (06/04/24) |
|
|
75 mg caps.x 10 | $79612.10 | (06/04/24) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $15478.18 |
|
|
|
|
75 mg caps.x 30 | $145475.35 | (06/04/24) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $28283.03 |
|
|
|
|
|